Cardio Diagnostics director receives option grant
Cardio Diagnostics Holdings director Burton Paul Frederick received a grant of stock options as compensation.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Cardio Diagnostics Holdings director Burton Paul Frederick received a grant of stock options as compensation. He was awarded 3,205 options to buy Common Stock at an exercise price of $1.95 per share, expiring on March 31, 2036. Following this grant, he holds 10,464 derivative securities directly.
Insider Trade Summary
Grant/Award: 3,205 shares
Grant/Award
1 txn
Insider
Burton Paul Frederick
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (Right to Buy) | 3,205 | $1.95 | $6K |
Holdings After Transaction:
Stock Options (Right to Buy) — 10,464 contracts (Direct)
Key Figures
Options granted: 3,205 options
Exercise price: $1.95 per share
Expiration date: March 31, 2036
+1 more
4 metrics
Options granted
3,205 options
Stock Options (Right to Buy) granted to director
Exercise price
$1.95 per share
Conversion or exercise price for granted options
Expiration date
March 31, 2036
Option expiration for this grant
Total derivative holdings
10,464 options
Total options held following the transaction
Key Terms
Stock Options (Right to Buy), grant/award acquisition, Common Stock, derivative securities
4 terms
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
grant/award acquisition financial
"transaction_action: grant/award acquisition"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
derivative securities financial
"derivativeTransactionCount for all derivative-type records"
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Cardio Diagnostics (CDIO) report for Burton Paul Frederick?
Cardio Diagnostics reported that director Burton Paul Frederick received a grant of stock options. He was awarded 3,205 derivative securities giving him the right to buy Common Stock, reflecting routine equity-based compensation rather than an open-market purchase or sale.
How many Cardio Diagnostics (CDIO) stock options were granted in this Form 4?
The Form 4 shows a grant of 3,205 stock options. Each option represents the right to buy one share of Cardio Diagnostics Common Stock, increasing the director’s total derivative holdings to 10,464 options after the transaction.
What is the exercise price of the Cardio Diagnostics (CDIO) options granted?
The granted stock options have an exercise price of $1.95 per share. This means the director can acquire Cardio Diagnostics Common Stock at $1.95, regardless of the market price, if he exercises the options before they expire.
When do the newly granted Cardio Diagnostics (CDIO) options expire?
The options granted to the director expire on March 31, 2036. He can choose to exercise the right to buy Common Stock at $1.95 per share any time up to that expiration date, subject to applicable vesting and plan terms.
Did the Cardio Diagnostics (CDIO) Form 4 show any open-market buying or selling?
The Form 4 reflects a grant or award acquisition of stock options, not an open-market trade. The transaction code is “A,” indicating a grant, meaning there was no market purchase or sale of existing Cardio Diagnostics shares in this filing.
How many Cardio Diagnostics (CDIO) derivative securities does the director hold after this grant?
After the grant, the director holds 10,464 derivative securities. These represent total stock options reported as directly owned, giving him the right to acquire an equivalent number of Cardio Diagnostics Common Stock shares according to the plan terms.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates